|
|
||||||
Journal of Clinical Oncology, Vol 22, No 17 (September 1), 2004: pp. 3558-3562 © 2004 American Society of Clinical Oncology. DOI: 10.1200/JCO.2004.11.152 Genetic Variation in the Leptin Receptor Gene and Obesity in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor StudyFrom the Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas; Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston, TX; Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Division of Pediatric Hematology Oncology; Memorial Sloan-Kettering Cancer Center, New York, NY; and Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA Address reprint requests to Julie A. Ross, PhD, Division of Pediatric Epidemiology and Clinical Research, University of Minnesota Cancer Center, 420 Delaware St SE, MMC 422, Minneapolis, MN 55455; e-mail: ross{at}epi.umn.edu
PURPOSE: Overweight (body mass index [BMI] 25 to 29 kg/m2) and obesity (BMI PATIENTS AND METHODS: We genotyped 600 non-Hispanic white adult ALL survivors enrolled onto the Childhood Cancer Survivor Study. BMI was compared between those with two copies of the Arg allele to those who had at least one copy of the Gln allele.
RESULTS: Female survivors with BMI CONCLUSION: LEPR polymorphism may influence obesity in female survivors of childhood ALL, particularly those exposed to cranial radiation. Because obesity is associated with increased morbidity and mortality in later life, identification of children at high risk might allow for early targeted interventions. Supported by grants from the National Cancer Institute (U24 CA-55727), Bethesda, MD, and the Children's Cancer Research Fund, Minneapolis, MN. Presented at the American Society of Hematology Meeting, San Diego, CA, December 6-9, 2003. Authors' disclosures of potential conflicts of interest are found at the end of this article. This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|